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Abstract
Background: There is a considerable controversy regarding safety of transvenous lead extra-
ction (TLE) in elderly patients due to their potentially worse general condition, more conco-
mitant diseases, more difficult sedation or analgesia. Moreover, the present experience is not 
relevant. The aim of the study was the comparison of safety and feasibility of TLE in elderly 
and middle-aged patients.
Methods: We have extracted an ingrown pacemaker (PM)/implantable cardioverter-defibril-
lator (ICD) leads from 1,060 adult patients (21–70 years) and 192 octogenarians (mean age 
83.4 ± 3.1 years) using standard mechanical systems within the last 7 years. We compared 
effectiveness and complications of the TLE procedures in the two mentioned groups of patients.
Results: There were more women in octogenarians referred for TLE (45.3% vs. 36.9%). In 
addition, more pocket infections (37.0% vs. 24.5%), less non-infective indications for PM 
(46.9% vs. 57.7%) and ICD systems (7.3% vs. 28.8%) TLE were observed in this group. Leads 
body dwelling time was similar (76.4 ± 56.8 vs. 83.5 ± 63.0) in both groups. Procedure effi-
cacy (full radiological success 97.4% vs. 94.6%, partial radiological success 2.6% vs. 4.34%), 
safety measures (major complications 1.6% vs. 1.51%, minor complications 1.0% vs. 1.9%) 
were similar in both compared groups.
Conclusions: Old age does not influence TLE effectiveness. Therefore, TLE can be safely and 
successfully performed in octogenarians. (Cardiol J 2014; 21, 1: 47–52)
Key words: transvenous lead extraction, permanent pacing complications,  
elderly, octogenarians
Introduction
The number of elderly patients with pacema-
ker (PM) and implantable cardioverter-defibrillator 
(ICD) remains still growing due to the global po-
pulation aging, which results in increased subpo-
pulation of elderly patients with late PM/ICD 
complications, such as infections or other lead 
related complications [1]. Transvenous lead ex-
traction (TLE) became a life-saving procedure 
in patients with device infection or other serious 
complications [2], and an accepted method of 
secondary prevention from lead related compli-
cations [3]. There is a considerable controversy 
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regarding TLE safety in elderly patients due to 
their potentially worse general condition, more 
concomitant diseases and additional difficulties in 
sedation or analgesia. Until now, there have been 
4 available reports concerning safety and effecti-
veness of lead extraction in elderly patients [4–7]. 
Octogenarians are considered poor candidates for 
invasive procedures including TLE because of 
many comorbidities.
We aimed at evaluating the safety and effecti-
veness of TLE procedures in octogenarian patients 
in comparison to middle-aged population.
Methods
We performed retrospective analysis of data 
achieved from 1,289 consecutive patients referred 
to our reference center for TLE with infective or 
non-infective indications between March 2006 and 
January 2013. Indications for lead extraction and 
definition of procedural outcomes (i.e. success and 
complications) followed the Heart Rhythm Society 
(HRS) Expert’s Consensus on transvenous lead 
extraction [8].
The patients population was divided into three 
age groups: 36 patients in the age below 20 years 
(young patients), 1,060 patients between 20– 
–79 years (middle-aged, adults) and 192 patients 
80 years old and more (octogenarian group). The 
first group was excluded from this study due to 
extreme differences in extraction of lead implanted 
in childhood and later, and we have compared only 
adults with octogenarians patients (1,252 patients). 
Baseline clinical and procedural data and outcomes 
were compared between these two age groups.
TLE procedure
After obtaining written informed consent, the 
TLE procedures were performed by one operator 
— previously trained and experienced electro-
physiologist from referential center on late pacing 
complications management. Lead extraction pro-
cedures were performed under conscious sedation 
or analgesia. All mandatory safety procedures (e.g. 
blood cross-matched, invasive arterial pressure 
monitoring through arterial line, prepared chest 
operating field and other) were employed in case 
of more than 12 years old leads or diagnosed per-
foration; in this situation TLE procedures were 
performed in cardiac surgery operating room. TLE 
of younger leads was performed in electrophysio-
logical laboratory with standard cardiac surgeon’s 
team standby. Intraoperative echocardiography was 
performed at the discretion of the operator, and 
routine postoperative echocardiographic exam was 
performed every time on the next day.
The leads were extracted through a subclavian 
approach adopting 3 techniques. The first one 
was simple gentle manual screwing-out/traction, 
consisting of the removal of a lead using manual 
tools such as stylets (usually non-locking) only in 
case of leads implanted less than 2 years ago, and 
no need for recapture of subclavian venous entry. 
The second technique was extraction using cutting-
-rotation forces with mechanical sheath, consisting 
of lead removal through a polypropylene dilator 
sheath (Byrd, Cook Vascular Inc, Leechburg, PA, 
USA, all sizes and diameters), and both locking 
and non-locking stylets. The last technique re-
presented other than lead venous entry approach 
and dedicated or non-dedicated tools for extraction 
of spontaneously broken leads with proximal en-
ding dropped into the cardiovascular system and 
broken lead fragments from femoral, right jugular 
or preserved previous broken lead venous entry 
approach [9–11].
Outcomes
After TLE procedures, all patients were ob-
served toward native heart rhythm stability and 
possibility of delayed symptoms of periprocedural 
major and minor complications. Definitions of major 
and minor complications were adopted from HRS 
Expert Consensus 2009 [8].
Statistical analysis
The values presented are expressed as mean 
± standard deviation (SD) for continuous variables 
showing normal distribution, and as frequencies 
and percentages for categorical data. Comparisons 
between the two age groups were performed using 
the independent Student t-test or c2, as appropriate.
Total population characteristics
The whole study population consisted of 1,252 
patients (774 males; 61.8%) aged 21–94 (average 
65.9 ± 14.4) years. Main indications for TLE pro-
cedures are summarized in Table 1.
Device infection was the main indication for 
lead extraction, and was present among 553 (44%) 
cases. Most of TLE procedures were performed 
due to different non-infective indications (56%). 
Data concerning non-infective indications were 
summarized in Table 1. There were 392 (31%) sin-
gle chamber, 705 (56%) dual chamber system, 145 
(11%) three chamber systems, and 7 (0,6%) four 
chamber systems. We have noted 1 vacant lead in 
145 (11%), 2 abandoned leads in 67 (5%), 3 or 4 in 
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7 (0.8%) cases. The total number of extracted leads 
was 2,137, matching on average 1.8 ± 0.78 leads 
per patient. We have removed 914 atrial leads, 
1145 right ventricular leads, and 78 left ventricular 
coronary sinus leads.
Results
The main clinical characteristics of the study 
population sorted according to age (octogenarians 
vs. younger adult patients) and the main procedural 
data and outcomes are summarized in Table 2.
The difference between the mean age in both 
groups was over 21 (83 vs. 62) years, likewise, the 
difference between the median (83 vs. 66 years). 
There were only 478 (38.2%) females in the whole 
population referred for TLE procedures, however, 
women were significantly dominant among octo-
genarians 87/192 (45.3%) than younger patients 
391/1060 (36.9%). The proportion of device-related 
sepsis/endocarditis were similar in both compared 
groups, yet, the percentage of pocket infection 
(abscess, skin erosion, chronic draining sinus, 
skin adherence etc.) was higher in octogenarians 
(37.0% vs. 24.5%). Non-infective indications (re-
capture of venous approach, potentially dangerous 
lead, lead interference with other system or with 
management of malignancy, excess of functional or 
non-functional leads, symptomatic venous occlu-
sion) were less frequent in octogenarians than in 
other adult patients (46.9% vs. 57.7%). Complexity 
of the system was understood as the number of 
leads in heart before lead extraction (active and 
abandoned leads). The number of extracted leads 
in 1 patient, number of leads in the system before 
TLE (only active leads) and number of abandoned 
leads before TLE were similar in both compared 
groups of patients. Likewise, coronary sinus lead 
presence/extraction did not differ between the 
groups (16.1% vs. 15.3%). The type of the device 
also differed significantly in the two age groups, 
with lower rate of ICDs among octogenarians 
(7.3% vs. 28.8%). Additionally, we evaluated pre-
operative chest X-ray examination to look for too 
Table 1. Main indications for transvenous lead extraction (TLE) procedures.
Main indication for TLE Class of indication Procedures Percent
Lead dependent endocarditis or sepsis 1 223 17.81%
Pocket infection (abscess, skin erosion, chronic draining  
sinus, skin adherence etc.)
1 330 26.36%
Recovery of venous approach in case of bilateral subclavian  
veins or VCS occlusion for transvenous lead implantation or 
contraindication of collateral side usage (arterio-venous fistula, 
vascular access port, mastectomy) or in case of no  
contraindication for contralateral side use 
1 or 2b 87 6.95%
VCS syndrome with limited symptoms 1 4 0.32%
Lead which may pose an immediate threat for the patient  
if left on site
1 20 1.60%
Life threatening arrhythmias secondary to retained lead  
or piece of the lead
1 2 0.16%
Lead interference with an active CIED system tumor therapy 1 16 1.28%
Chronic pain at device site 2a 7 0.56%
Implantation requiring more than 4 leads in SV, or over 5 in VCS 2a 4 0.32%
Lead which may pose a threat to the patient if left in place, 
prophylactic lead replacement
2b 33 2.63%
Superfluous functional lead; extraction during CIED procedure 
when contraindications are absent (excess of leads functional, 
change of pacing mode, upgrading)
2b 52 4.15%
Superfluous lead non-functional; extraction during CIED  
procedure when contraindications are absent (dislodgement, 
exit/entry block, permanent AF, defective/damaged,  
overmuch nonfunctional)
2b 459 36.66%
Missed tip location (out of standard position),  
symptomatic perforation
3 15 1.20%
All TLE procedures 1,252 100%
AF — atrial fibrillation; CIED — cardiac implantable electronic devices; SV — subclavian vein; VCS — vena cava superior
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long loops of lead in right heart cavities, double lead 
crossing the tricuspid valve. The phenomenon not 
only disturbs tricuspid valve functionality, but also 
may render lead extraction difficult and favor tricu-
spid system damage during TLE. The percentage of 
this faultiness was similar in both groups (5.7% vs. 
7.0%). System duration expressed as mean leads 
body dwelling time and number of procedures (unit 
replacements, upgrades, lead replacements, etc.) 
before lead extraction were similar (76.4 vs. 83.5 
months and 1.99 vs. 1.95 procedures).
Table 2 contains analysis and comparison of 
procedural outcomes. Full radiological success 
(extraction of all leads) was very high and similar 
in both compared groups (97.4% vs. 94.6%). Per-
centages of partial radiological success, indicating 
tip of the lead or piece of the lead shorter than 4 cm 
left in the atrial or ventricular wall with full clinical 
success in all cases were similar (2.6% vs. 4.3%).
A total of 17 (1.35%) major complications 
occurred among 1,252 TLE procedures in the 
periprocedural period, consisting of 4 (0.31%) 
deaths. The major complications were: 12 cardiac 
tamponade (9 cardiac surgeries, 3 pericardial 
drainages, 2 patients died in spite of a successful 
operation), 1 massive pulmonary embolism and 
1 severe hypotonia and contractility depression 
(both patients died), 2 hemothoraces as results 
of vena cava tear (1 thoracotomy) and 1 cerebral 
stroke. Additionally, 1 patient died 2 weeks after 
effective TLE procedure as a result of severe recur-
rence of sepsis after the new system implantation.
Major complications occurred in identical per-
centage in octogenarians and in other adult patients 
(1.56% vs. 1.51%).
Minor complications occurred in 19 (1.52%) 
patients, and consisted of 6 diminutive heart wall 
tears with asymptomatic epicardial fluid not re-
Table 2. The main clinical characteristics of the study population sorted according to age (octogena-
rians vs. younger adult patients) and the main procedural data and outcomes.
Patient/system/procedure information ≥ 80 years 21–79 years P
Number of patients 192 1060 –
Patient’s age 83.4 ± 3.10 62.7 ± 13.4 0.000001
Sex — males (% of male patients) 105 (54.7%) 669 (63.1%) 0.0331
Infective endocarditis, sepsis 31 (16.1%) 189 (17.8%) 0.6446
Pocket infection (abscess, skin erosion, chronic draining  
sinus, skin adherence etc.)
71 (37.0%) 259 (24.5%) 0.0004
Non-infective indications (recapture of venous approach, 
dangerous lead, lead interference, overmuch of functional  
or non-functional leads, symptomatic venous occlusion)
90 (46.9%) 611 (57.7%) 0.0072
Number of leads in heart before lead extraction 2.06 ± 0.77 2.01 ± 0.81 0.4280
Number of extracted leads in 1 patient 1.78 ± 0.86 1.70 ± 0.81 0.2126
Number of leads in the system before TLE 1.84 ± 0.65 1.81 ± 0.66 0.561433
Number of abandoned leads before TLE 0.26 ± 0.61 0.24 ± 0.59 0.6673
CS (LA, LV) lead extraction 31 (16.1%) 162 (15.3%) 0.8446
High voltage therapy (ICD) lead extraction 14 (7.3%) 305 (28.8%) 0.000001
Too long loops of lead in right heart cavities with  
double lead crossing of  tricuspid valve 
11 (5.7%) 74 (7.0%) 0.6322
Number of procedures before lead extraction 1.99 ± 1.23 1.95 ± 1.22 0.6764
Mean leads body dwelling time [months] 76.4 ± 56.8 83.5 ± 63.0 0.1451
Full radiological success 187 (97.4%) 1002 (94.6%) 0.1354
Partial radiological success 5 (2.6%) 46 (4.34%) 0.3571
Major complications 3 (1.56%) 16 (1.51%) 0.7907
Minor complications 2 (1.00%) 20 (1.88%) 0.6019
Technical problems during TLE (extracted lead breakage,  
extracted lead fragmentation and its removal in parts,  
polypropylene sheath facture, lead to lead strong connection 
with connecting tissue scar, dislodgement of functional  
lead, problem with sheath passing via lead subclavian  
entry, necessity to change of venous approach etc.)
28 (14.6%) 172 (16.23%) 0.6421
Operating room stay-in time (whole procedure duration) [min] 103.9 ± 45.7 111.4 ± 47.7 0.0776
ICD — implantable cardioverter-defibrillator; CS — coronary sinus; LA — left atrium; LV — left ventricle; TLE — transvenous lead extraction 
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quiring drainage, 4 aggravations of tricuspid valve 
dysfunction, 3 vena cava tears causing small right 
pleural effusion not requiring drainage, 3 mild 
pulmonary embolisms diagnosed in computer to-
mography not requiring intervention, 2 vascular 
tears causing local thrombosis with conservative 
treatment, and 1 intraoperative bleeding requiring 
pre-discharge blood transfusion. No statistically 
significant differences in the rates of minor com-
plications were found between octogenarians and 
younger patients group (1.00% vs. 1.88%).
Difficulty of TLE procedure represents frequ-
ency of appearance of technical problems, which 
prolongs procedure and usually enforces the ope-
rator to use additional tools and additional vascular 
approach as well. Percentage of transient technical 
problems, which occurred during TLE procedure 
was similar in both groups of patients (14.6% vs. 
16.2%). The whole TLE procedure duration time 
expressed as average operating room stay-in time 
was nearly identical (103.9 vs. 111.4 min).
Discussion
To the best of our knowledge, this is the 5th, 
and the largest study (significantly longer implant 
duration in the described patients also seems to 
be important) reporting the safety and effective-
ness of TLE in octogenarians, similar to previous 
4 reports [4–7], that advanced age does not affect 
the safety and efficacy of TLE procedures. As in 
previous reports, the problem of optimal mana-
gement of old patients with different late pacing 
complications still remains controversial. On the 
one hand, longer population life-time prompts 
an increase of the number of PM/ICD/cardiac 
resynchronization therapy (CRT) recipients, and 
consequently multiplies further procedures (unit 
replacements, system upgrades, lead replace-
ments and other). The number of elderly patients 
presenting device-related infection or malfunction 
eligible for lead extraction is expected to increase 
[1–3]. On the other hand, old age and associated 
comorbidities of implantable cardiac device reci-
pients restrains form referral for TLE, especially 
in cases of non-infective indications. Kennergren 
et al. [12] reported that in some patients TLE was 
not performed only because of advanced age. In 
a recent European survey we have also articulated 
concerns about the age as an independent factor 
inclining the operator to avoid TLE if possible [13].
Our study demonstrated significantly more 
women among octogenarians (45.3%) than among 
younger patients (36.9%). It might be the effect 
of longer mean life-span in women than in men. 
Nevertheless, higher percentage of female pa-
tients (known TLE complications risk factor) did 
not influence frequency of TLE complication. It 
is difficult to explain higher frequency of pocket 
infections (37.0% vs. 24.5%) in octogenarians. 
The rate of these patients’ reference for TLE due 
to other non-infective indications may be lower. In 
spite of similar system complexity in both groups 
of patients, we noted a lower rate of ICDs among 
octogenarians (7.3% vs. 28.8%).
System duration in our patients expressed as 
mean leads body dwelling time (76.4 months in 
octogenarians and 83.5 months in younger adult 
patients) is significantly longer than in 4 cited 
reports [4–7].
We have presented that effectiveness of TLE 
procedures expressed as percentage of radiological 
success (97.4% vs. 94.6%) and percentage of partial 
radiological success but with full clinical success 
were similar (2.6% vs. 4.3%). Major complications 
occurred in identical percentage in octogenarians 
and in other adult patients (1.56% vs. 1.51%), si-
milarly did minor complications (1.00% vs. 1.88%). 
The TLE in octogenarians was not connected with 
additional technical problems (14.6% vs. 16.2%) 
and the whole procedure duration was similar in 
older and younger patients (103.9 vs. 111.4 min).
The largest reports of Pelargonio et al. [4], 
Rodriguez et al. [6], and Williams et al. [7] indicate 
that the majority of patient population underwent 
lead extraction because of device-related infection, 
which represents a mandatory indication for lead 
extraction. In contrast, 47% of our octogenarian 
patients were referred for TLE due to non-infective 
indications.
Important part of the TLE procedure consists 
of sedation/analgesia and periprocedural intensive 
care. The role of experienced anesthesiologist 
cannot be underestimated.
Authors impression
We have an impression never to meet signifi-
cant calcification of connecting tissue scar surro-
unding over 12 years old lead in octogenarians. It 
was a relatively frequent finding in adult patients, 
particularly before 3rd and 4th decade. The lack of 
this phenomenon may partly explain a relatively 
high effectiveness of TLE using mechanical tools 
only. This, however, was not analyzed in this study.
Limitations of the study
Our study included a retrospective analysis 
of data from consecutive patients referred to 
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a single center specialized in the management of 
late permanent cardiac pacing complications. Due 
to positive opinion of our center and previous edu-
cational effort on management of late PM/ICD/CRT 
complications, the role of referring doctors seems 
to be limited and we may believe that only small 
percentage of elderly patients were not referred 
due to worse general conditions and multiple 
comorbidities. Similar schedule of indications for 
TLE in both age groups seems to confirm this 
concept.
It is important that procedures were perfor-
med only by one experienced operator, and the 
results should not be generalized to other, less-
-experienced centers and operators.
Conclusions
Transvenous lead extraction has similar ef-
ficacy and safety in octogenarians as in younger 
patients. Advanced age per se should not restrict 
the utility of lead extraction therapy in patients 
with late PM/ICD/CRT complications.
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